Dermacyd Silver Frutal (Lactic Acid) - Compatibility.
Phase 3
Completed
- Conditions
- Hygiene
- Interventions
- Drug: LACTIC ACID(ND)
- Registration Number
- NCT00933946
- Lead Sponsor
- Sanofi
- Brief Summary
Primary Objective:
To demonstrate the absence of irritation potential (primary dermic irritability and cumulated dermic irritability) and allergy (sensibilization) of the product Dermacyd Silver Frutal.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 55
Inclusion Criteria
Not provided
Exclusion Criteria
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description Dermacyd Silver Frutal (Lactic Acid) LACTIC ACID(ND) Dermacyd Silver Frutal (Lactic Acid) sample will be applied like a curative. Physiologic solution and mineral oil will be also used as a control sample.
- Primary Outcome Measures
Name Time Method Evaluation of the absence of primary and accumulated dermical irritability and dermical sensitivity by using International Contact Dermatitis Research Group (ICDRG) scale. from the treatment start to the end of the study (treatment period 6 weeks)
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie the dermal compatibility of lactic acid-based formulations like Dermacyd Silver Frutal?
How does lactic acid in Dermacyd Silver Frutal compare to other alpha hydroxy acids in terms of skin irritation profiles and clinical efficacy?
Are there specific biomarkers that correlate with enhanced skin barrier function in response to silver lactic acid treatments?
What are the potential adverse events associated with silver lactic acid formulations in phase 3 dermatological trials?
What alternative antimicrobial agents are being evaluated for skin hygiene applications compared to Dermacyd Silver Frutal's approach?
Trial Locations
- Locations (1)
Sanofi-Aventis Administrative Office
🇧🇷Sao Paulo, Brazil
Sanofi-Aventis Administrative Office🇧🇷Sao Paulo, Brazil